Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. ... Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Heart failure, part two. Now it's time for the bummer news about heart failure (HF). ... But, as Philip Poole-Wilson, MD, said in his inimitable English accent about the exercise and heart failure study: "Safety without benefit is a bit dull, really.".
QD: News Every Day--9 performance measures for heart failure expand use of beta-blockers to inpatient care, among other recommendations
outcomes. "In order to improve the quality of heart failure care, one has to provide measures of quality. ... Eight measures from the previous heart failure performance measures set, which were released in 2005, were retired.
not have heart failure, after adjustment for BMI, smoking, and Charlson comorbidity index. ... non-cardiac morbidity and of cancer surveillance in the management of [heart failure] patients.".
Palliative care's place in noncancer morbidity | Internal Medicine Meeting 2019 News | ACP Internist
In heart failure and COPD, there is no time when stopping disease-modifying medications is actually helpful.”. ... All conditions have palliative care needs, she continued. Studies are continually published showing that palliative care can benefit
to have an accompanying editorial called “Rethinking the focus of heart failure quality measures.” Both were authored by luminaries in the field. ... This is, of course, hard to pull off, because of the challenges associated with “managing
Instead, they should describe those patients as having “heart failure in remission,” she said. ... To identify worsening heart failure, physicians can ask a patient two key questions, Dr.
Yup. He just had bad heart failure. Period. And sometimes bad heart failure just misbehaves without much provocation. ... We optimized his blood pressure meds. We restricted his fluids. And we consulted the heart failure team.
HF-ACTION involved 2,331 heart failure patients (average age, 59 years) who were followed for about 2.5 years. ... Researchers tested whether irbesartan (Avapro) might lower death and hospitalizations for heart failure, myocardial infarction, stroke and
Heart failure and exercise. It's heart failure day at AHA Scientific Sessions-- at least in terms of the late-breaking trials. ... During a press conference about some of these trials, several physicians bemoaned the fact that the general public knows